Patents by Inventor Michael Moffitt

Michael Moffitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11995802
    Abstract: An inspection apparatus includes a specimen stage, one or more imaging devices and a set of lights, all controllable by a control system. By translating or rotating the one or more imaging devices or specimen stage, the inspection apparatus can capture a first image of the specimen that includes a first imaging artifact to a first side of a reference point and then capture a second image of the specimen that includes a second imaging artifact to a second side of the reference point. The first and second imaging artifacts can be cropped from the first image and the second image respectively, and the first image and the second image can be digitally stitched together to generate a composite image of the specimen that lacks the first and second imaging artifacts.
    Type: Grant
    Filed: May 26, 2023
    Date of Patent: May 28, 2024
    Assignee: Nanotronics Imaging, Inc.
    Inventors: Matthew C. Putman, John B. Putman, John Moffitt, Michael Moskie, Jeffrey Andresen, Scott Pozzi-Loyola, Julie Orlando
  • Publication number: 20240157157
    Abstract: A system and method for selecting leadwire stimulation parameters includes a processor iteratively performing, for each of a plurality of values for a particular stimulation parameter, each value corresponding to a respective current field: (a) shifting the current field longitudinally and/or rotationally to a respective plurality of locations about the leadwire; and (b) for each of the respective plurality of locations, obtaining clinical effect information regarding a respective stimulation of the patient tissue produced by the respective current field at the respective location; and displaying a graph plotting the clinical effect information against values for the particular stimulation parameter and locations about the leadwire, and/or based on the obtained clinical effect information, identifying an optimal combination of a selected value for the particular stimulation parameter and selected location about the leadwire at which to perform a stimulation using the selected value.
    Type: Application
    Filed: January 25, 2024
    Publication date: May 16, 2024
    Inventors: Stephen Carcieri, Dean Chen, Michael A. Moffitt
  • Patent number: 11980765
    Abstract: A neurostimulation system configured for providing neurostimulation therapy to a patient. A user customizes a pulse pattern on a pulse-by-pulse basis. Electrical stimulation energy is delivered to at least one electrode in accordance with the customized pulse pattern.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: May 14, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Michael A. Moffitt
  • Publication number: 20240123234
    Abstract: An examples of a system for delivering neurostimulation to a patient may include a stimulation output circuit configured to deliver the neurostimulation, a sensing circuit configured to sense a neural signal indicative of neural responses to the neurostimulation, and stimulation control circuit. The stimulation control circuit may be configured to control the delivery of the neurostimulation using a plurality of stimulation parameters and may be configured to detect morphological features of the neural responses, to produce a neural response parameter using the detected morphological features, to detect a change in the sensed neural signal, to analyze the produced neural response parameter for attributing the detected change to one of a neural activation change in the patient or a body movement of the patient, and to control a dynamically controlled stimulation parameter of the plurality of stimulation parameters using the sensed neural signal and an outcome of the analysis.
    Type: Application
    Filed: October 13, 2023
    Publication date: April 18, 2024
    Inventors: Rosana Esteller, Max Witwer, Tianhe Zhang, Michael A. Moffitt
  • Publication number: 20240123255
    Abstract: A system for percutaneous photobiomodulation (PBM) that can deliver light that is configured outside the body directly to target tissue is described. The system can be used to treat both chronic and temporary conditions with PBM. The system includes a light source and a controller that includes a memory storing a predefined dosing requirement and a processor to access the memory and signal the light source to generate a light signal for PBM of a target area within a patients body based on the predefined dosing requirement. In some instances, the system also includes a port to deliver the light signal received from the light source to the target area. The light source and the port can be connected by an attachment that can transmit the light signal from the light source to the port.
    Type: Application
    Filed: February 21, 2022
    Publication date: April 18, 2024
    Inventors: Michael MOFFITT, Michael JENKINS
  • Publication number: 20240123236
    Abstract: A neuromodulation system for use with electrodes to modulate a volume of neural tissue may include a waveform generator and a controller. The waveform generator may be configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a neuromodulation therapy. The controller may be configured to use a program to control the waveform generator to deliver a neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation. The fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 18, 2024
    Inventor: Michael A. Moffitt
  • Patent number: 11957915
    Abstract: A method of treating a patient and an external programmer for use with a neurostimulator. Electrical stimulation energy is conveyed into tissue of the patient via a specified combination of a plurality of electrodes, thereby creating one or more clinical effects. An influence of the specified electrode combination on the clinical effect(s) is determined. An anatomical region of interest is displayed in registration with a graphical representation of the plurality of electrodes. The displayed anatomical region of interest is modified based on the determined influence of the specified electrode combination on the clinical effect(s).
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: April 16, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, John J. Reinhold
  • Patent number: 11951314
    Abstract: Methods for determining stimulation for a patient having a stimulator device are disclosed. A model is received at an external system indicative of a range or volume of preferred stimulation parameters, which model is preferably specific to and determined for the patient. The external system receives a plurality of pieces of fitting information for the patient, including information indicative of a symptom of the patient, information indicative of stimulation provided by the stimulator device during a fitting procedure, and/or phenotype information for the patient. The external system determines one or more sets of stimulation parameters for the patient using the pieces of fitting information. In one example, training data is applied to the pieces of fitting information to select the one or more sets of stimulation parameters from the range or volume of preferred stimulation parameters in the model.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: April 9, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Ismael Huertas Fernandez, Que T. Doan, Michael A. Moffitt, Changfang Zhu
  • Publication number: 20240108897
    Abstract: Methods, apparatuses and systems for ophthalmic therapy. Electrical therapy delivery characteristics are determined using a testing or calibration phase and a patient's known disease state. Expected values for phosphene thresholds in the patient's eye are used along with measurements characterizing a relationship between therapy output from electrodes near the eye to the energy that is actually received at the eye, such as by corneal measurements. The result may include a determination of therapy delivery targets and/or an estimate of the patient's disease state.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 4, 2024
    Inventors: James R. Chiapetta, Michael A. Moffitt
  • Patent number: 11944823
    Abstract: Methods and systems can facilitate identifying effective electrodes and other stimulation parameters, as well as determining whether to use cathodic and anodic stimulation. Alternately, the methods and systems may identify effective electrodes and other stimulation parameters based on preferential stimulation of different types of neural elements. These methods and systems can further facilitate programming an electrical stimulation system for stimulating patient tissue.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: April 2, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Stephen Carcieri
  • Patent number: 11944816
    Abstract: Methods and systems for testing and treating spinal cord stimulation (SCS) patients are disclosed. Patients are eventually treated with sub-perception (paresthesia free) therapy. However, supra-perception stimulation is used during “sweet spot searching” during which active electrodes are selected for the patient. This allows sweet spot searching to occur much more quickly and without the need to wash in the various electrode combinations that are tried. After selecting electrodes using supra-perception therapy, therapy is titrated to sub-perception levels using the selected electrodes. Such sub-perception therapy has been investigated using pulses at or below 10 kHz, and it has been determined that a statistically significant correlation exists between pulse width (PW) and frequency (F) in this frequency range at which SCS patients experience significant reduction in symptoms such as back pain.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: April 2, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Que T. Doan, Jianwen Gu, Ismael Huertas Fernandez, Rosana Esteller, Michael A. Moffitt
  • Patent number: 11938328
    Abstract: A system and method for selecting leadwire stimulation parameters includes a processor iteratively performing, for each of a plurality of values for a particular stimulation parameter, each value corresponding to a respective current field: (a) shifting the current field longitudinally and/or rotationally to a respective plurality of locations about the leadwire; and (b) for each of the respective plurality of locations, obtaining clinical effect information regarding a respective stimulation of the patient tissue produced by the respective current field at the respective location; and displaying a graph plotting the clinical effect information against values for the particular stimulation parameter and locations about the leadwire, and/or based on the obtained clinical effect information, identifying an optimal combination of a selected value for the particular stimulation parameter and selected location about the leadwire at which to perform a stimulation using the selected value.
    Type: Grant
    Filed: March 7, 2023
    Date of Patent: March 26, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Stephen Carcieri, Dean Chen, Michael A. Moffitt
  • Publication number: 20240082579
    Abstract: Software for providing a Graphical User Interface (GUI) for use in a clinician programmer for programming an implantable pulse generator (IPG) or external trial stimulator (ETS) is disclosed. A user may define in the GUI multiple pole configurations (e.g., monopoles, bipoles, etc.) which may be used independently to provide stimulation to a patient via the IPG or ETS's electrode array. Selected of the pole configurations can be linked or associated as a group in the GUI and used to concurrently provide stimulation. The pole configuration group may be steered or moved in the electrode array using a single movement instruction which moves all pole configurations in the group simultaneously. This allows the relative positions of the pole configurations in the group to remain constant as the group is moved.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 14, 2024
    Inventors: Michael A. Moffitt, Que T. Doan
  • Patent number: 11923093
    Abstract: A computer implemented system and method provides a volume of activation (VOA) estimation model that receives as input two or more electric field values of a same or different data type at respective two or more positions of a neural element and determines based on such input an activation status of the neural element. A computer implemented system and method provides a machine learning system that automatically generates a computationally inexpensive VOA estimation model based on output of a computationally expensive system.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 5, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, G. Karl Steinke
  • Publication number: 20240065620
    Abstract: A system may include at least one medical device and a processing system. The medical device may be configured to treat a condition by delivering a therapy to a patient. The therapy is at least partially defined using a parameter set. The processing system may be configured for use to acquire clinical effect data (CED) for the condition, acquire a medication state of medication administered to treat the condition, adjust the CED based on the medication state to provide medication-adjusted CED, and identify an adjusted parameter set for the at least one medical device to deliver the therapy based on the medication-adjusted CED. The adjusted parameter set may be communicated to a clinician (or patient or other user) as a suggestion or may be automatically implemented to update the therapy.
    Type: Application
    Filed: August 30, 2023
    Publication date: February 29, 2024
    Inventors: Lisa Denise Moore, Michael A. Moffitt, Leon Mauricio Juarez Paz, Stephen Carcieri
  • Patent number: 11904168
    Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating a volume of neural tissue, where the neural tissue has an activation function. The system may further include a neural modulation generator configured to deliver energy using at least some electrodes to generate a modulation field within the volume of neural tissue. The neural modulation generator may be configured to use a programmed modulation parameter set to generate the modulation field. The programmed modulation parameter set having values selected to control energy delivery using the at least some electrodes to achieve an objective function specific to the activation function of the volume of neural tissue to promote uniformity of a response to the modulation field in the volume of neural tissue along a span of the at least one lead.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: February 20, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, Bradley Lawrence Hershey, Michael A. Moffitt, Changfang Zhu
  • Publication number: 20240050766
    Abstract: A system for subcutaneous photobiomodulation (PBM) is described. The system includes a light source that can generate light inside the body (subcutaneously) and a light transmission medium and an emitter that can deliver the light directly to a target location within tissue of the body to treat one or more medical conditions. For example, the light signal can be used to treat a medical condition, which can be controlled/regulated by at least one small nerve and the light signal can be configured for delivery to the at least one small nerve.
    Type: Application
    Filed: February 21, 2022
    Publication date: February 15, 2024
    Inventors: Michael MOFFITT, Stephen LEWIS, Michael JENKINS
  • Patent number: 11890480
    Abstract: A neuromodulation system for use with electrodes to modulate a volume of neural tissue may include a waveform generator and a controller. The waveform generator may be configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a neuromodulation therapy. The controller may be configured to use a program to control the waveform generator to deliver a neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation. The fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: February 6, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Michael A. Moffitt
  • Patent number: 11850426
    Abstract: Software for providing a Graphical User Interface (GUI) for use in a clinician programmer for programming an implantable pulse generator (IPG) or external trial stimulator (ETS) is disclosed. A user may define in the GUI multiple pole configurations (e.g., monopoles, bipoles, etc.) which may be used independently to provide stimulation to a patient via the IPG or ETS's electrode array. Selected of the pole configurations can be linked or associated as a group in the GUI and used to concurrently provide stimulation. The pole configuration group may be steered or moved in the electrode array using a single movement instruction which moves all pole configurations in the group simultaneously. This allows the relative positions of the pole configurations in the group to remain constant as the group is moved.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: December 26, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Que T. Doan
  • Publication number: 20230405342
    Abstract: Methods and systems for providing stimulation therapy are disclosed. Embodiments of the system include an implantable stimulator and an external controller configured to control the implantable stimulator. A clinician can prescribe a set amount of stimulation therapy to a patient. The external controller is programmed with the prescription. As the patient uses the external controller and the stimulator device the external controller tracks the amount of stimulation the patient uses. Once the patient has used all of the prescribed therapy the patient may return to the clinician for a follow-up appointment.
    Type: Application
    Filed: August 1, 2023
    Publication date: December 21, 2023
    Inventors: Michael A. Moffitt, Ismael Huertas Fernandez